Trinity Biotech

TRIB NASDAQ
2.490
+0.090
+3.75%
Closed 16:00 07/15 EDT
Open
2.420
Prev Close
2.400
High
2.600
Low
2.350
Volume
112.95K
Avg Vol (3M)
74.89K
52 Week High
5.20
52 Week Low
1.570
% Turnover
0.47%
Market Cap
59.86M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Trinity Biotech TRIB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
MORE >

Recently

Name
Price
%Change